Skip to main content
Have a personal or library account? Click to login
Synthesis and biological evaluation of some novel 1-substituted fentanyl analogs in Swiss albino mice Cover

Synthesis and biological evaluation of some novel 1-substituted fentanyl analogs in Swiss albino mice

Interdisciplinary Toxicology
Volume 7 (2014): Issue 2 (June 2014)
By: ,  ,  ,  ,   and    
Open Access
|Nov 2014
References

References

  1. Ananthan S. (2006). Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics. AAPS J 8: E118-E125.
    Search in Google Scholar
  2. Bagley JR, Kudzma LV, Lalinde NL, Colapret JA, Huang B-S, Lin B-S, Jerussi TP, Benvenga MJ, Doorley BM, Ossipov MH, Spaulding TC, Spencer HK, Rudo FG, Wynn RL. (1991). Evolution of the 4-anilidopiperidine class of opioid analgesics. Med Res Rev 11: 403-436.
    Search in Google Scholar
  3. Bi-Yi C, Wen-Qiao J, Jie C, Xin-Jian C, You-Cheng Z, Zhi-Qiang C. (1999). Analgesic activity and selectivity of isothiocyanate derivatives of fentanyl analogs for opioid receptors. Life Sci 65: 1589-1595.
    Search in Google Scholar
  4. Casy AF, Parfi tt RT. (1986). Opioid analgesics. Plennum NY Correa CR, Calixto JB. (1993). Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br J Pharmacol 110: 193-198.
    Search in Google Scholar
  5. Damas J, Liegeois JF. (1999). The infl ammatory reaction induced by formalin in the rat paw. Naunyn-Schmeidebergs Arch Pharmacol 359: 220-227.
    Search in Google Scholar
  6. Dixon WJ. (1965). The up-and-down method for small samples. J Amer Statist Assoc 60: 967- 978.
    Search in Google Scholar
  7. Feldman PL, James MK, Brackeen MF, Bilotta JM, Schuster SV, Lahey AP, Lutz MW, Johnson MR, Leighton HJ. (1991). Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics. J Med Chem 34: 2202-2208.
    Search in Google Scholar
  8. Gardocki JF, Yelnosky J. (1964). A study of some of the pharmacological actions of fentanyl citrate. Toxicol Appl Pharmacol 6: 48-62.
    Search in Google Scholar
  9. Gerak LR, Moerschbaecher JM, Bagley JR, Brockunier LL, France CP. (1999). Effects of a novel fentanyl derivative on drug discrimination and learning in rhesus monkeys. Pharmacol Biochem Behav 64: 367-371.
    Search in Google Scholar
  10. Gupta PK, Yadav SK, Bhutia YD, Singh P, Rao P, Gujar NL, Ganesan K, Bhattacharya R. (2013). Synthesis and comparative bioeffi cacy of N-(1- phenethyl-4-piperidinyl)propionanilide (fentanyl) and its 1-substituted analogs in Swiss albino mice. Med Chem Res 22: 3888-3896.
    Search in Google Scholar
  11. Hallenbeck JL. (2003). Palliative care perspective. Oxford University Press, Inc., New York Higashikawa Y, Suzuki S. (2008). Studies on 1-(2-phenethyl)-4-(N-propionylanilino) piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicol 26: 1-5.
    Open DOISearch in Google Scholar
  12. Hunskar S, Hole K. (1987). The formalin test in mice: dissociation between infl ammatory and non-infl ammatory pain. Pain 30: 103-114.
    Search in Google Scholar
  13. Irwin S. (1964). Drug screening and evaluation of new compounds in animals. in Animal and clinical techniques in drug evaluation (Nodin JH, Siegler PE eds) pp 36-54, Year Book Medical Publishers, Chicago.
    Search in Google Scholar
  14. Irwin S. (1968). Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioural and physiologic state of the mouse. Psychopharmacologia (Berl) 13: 222-257.
    Search in Google Scholar
  15. Jagerovic N, Cano C, Elguero J, Goya P, Callado LF, Meana JJ, Giron R, Abalo R, Ruiz D, Goicoechea C, Martin MA. (2002). Long-Acting Fentanyl Analogues: Synthesis and Pharmacology of N-(1-Phenylpyrazolyl)-N-(1-phenylalkyl-4- piperidyl)propanamides. Bioorg Med Chem 10: 817-827.
    Search in Google Scholar
  16. Janssen PAJ, Niemegeers CJE, Dony JGH. (1963). The inhibitory eff ect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal refl ex in rats. Arzneimittel-Forsch-Drug Res 13: 502-507.
    Search in Google Scholar
  17. Jumbelic MI. (2010). Deaths with transdermal fentanyl patches. Am J Forensic Med Pathol 31: 18-21.
    Search in Google Scholar
  18. Kalso E, Edwards JE, Moore RA, McQuay HJ. (2004). Opioids in chronic noncancer pain: systematic review of effi cacy and safety. Pain 112: 372-380.
    Search in Google Scholar
  19. Kieff er BL, Evans CJ. (2009). Opioid receptors: from binding sites to visible molecules in Vivo. Neuropharmacology 56: 205-212.
    Search in Google Scholar
  20. Kieff er BL. (1995). Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell Mol Neurobiol 15: 615-635.
    Search in Google Scholar
  21. Lambert DG. (2004). Drugs and receptors. Contin Educ Anaesth Crit Care Pain 4: 181-184.
    Search in Google Scholar
  22. Leavitt SB. (2009). Opioid antagonists, naloxone & naltrexene-Aids for pain management. An overview of clinical evidence. Pain Treatment Topics, Glenview, IL 60025 http: //Pain-Topics.Org, 1-16.
    Search in Google Scholar
  23. Lee YS, Nyberg J, Moye S, Agnes RS, Davis P, Ma SW, Lai J, Porreca F, Vardanyan R, Hruby VJ. (2007). Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at mu and delta opioid receptors. Bioorg Med Chem Lett 17: 2161-2165.
    Search in Google Scholar
  24. Lemmens H. (1995). Pharmacokinetic-pharmacodynamic relationships for opioids in balanced anaesthesia. Clin Pharmacokinet 29: 231-242.
    Search in Google Scholar
  25. Litchfi eld JTJr, Wilcoxon F. (1949). A simplifi ed method of evaluating dose-effect experiments. J Pharm Exp Ther 96: 99-113.
    Search in Google Scholar
  26. Mather LE. (1983). Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 8: 422-446.
    Search in Google Scholar
  27. Matosiuk D, Fidecka S, Antkiewicz-Michaluk L, Lipkowski J, Dybala I, Koziol AE. (2002). Synthesis and pharmacological activity of new carbonyl derivatives of 1-aryl-2-iminoimidazolidine. Part 2. Synthesis and pharmacological activity of 1,6-diaryl-5,7(1H)dioxo-2,3-dihydroimidazo[1,2-a][1,3,5]triazines. Eur J Med Chem 37: 761-772.
    Search in Google Scholar
  28. Mayes S, Ferrone M. (2006). Fentanyl HCl patient-controlled iontophoretic transdermal system for the management of acute postoperative pain: Summary/formulary recommendation. Ann Pharmacother 40: 2178-2186.
    Search in Google Scholar
  29. McGinty J, Friedman D. (1988). Opioids in the hippocampus. Natl Inst Drug Abuse Res Monogr Ser 82: 1-145.
    Search in Google Scholar
  30. Meunier CJ, Burton J, Cumps J , Verbeeck RK. (1998). Evaluation of the formalin test to assess the analgesic activity of difl unisal in the rat. Eur J Pharm Sci 6: 307-312.
    Search in Google Scholar
  31. Mićović IV, Ivanović MD, Vuckovic SM, Prostran MŠ, Došen-Mićović L, Kiricojević VD. (2000). The synthesis and preliminary pharmacological evaluation of 4-methyl fentanyl. Bioorg Med Chem Lett 10: 2011-2014.
    Search in Google Scholar
  32. Pasternak GW. (2004). Multiple opiate receptors: deja vu all over again. Neuropharmacology 47: 312-323.
    Search in Google Scholar
  33. Portoghese PS. (1992). The role of concepts in structure-activity-relationship studies of opioid ligands. J Med Chem 35: 1927-1937.
    Search in Google Scholar
  34. Scholz J, Steinfath M, Schulz M. (1996). Clinical pharmacokinetics of alfentanyl, fentanyl and sufentanyl. An update. Clin Pharmacokinet 31: 275-292.
    Search in Google Scholar
  35. Smith MT. (2008). Diff erences between and combinations of opioids re-visited. Curr Opin Anaesthesiol 21: 596-601.
    Search in Google Scholar
  36. Spetea M, Bohotin CR, Asim MF, Stubegger K, Schmidhammer H. (2010). In vitro and in vivo pharmacological profi le of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function. Eur J Pharm Sci 4: 125-135.
    Search in Google Scholar
  37. Vogel HG. (2002). Psychotropic and neurotropic activity. In Drug Discovery and Evaluation. Pharmacological Assays. Springer, Berlin.
    Search in Google Scholar
  38. Van Nimmen NFJ, Poels KLC, Veulemans HAF. (2004). Highly sensitive gas chromatographic- mass spectrometric screening method for the determination of picogram levels of fentanyl, sufentanil and alfentanil and their major metabolites in urine of opioid exposed workers. J Chromatogr B 804: 375-387.
    Search in Google Scholar
  39. Vučkovic S, Prostran M, Ivanović M, Dosen-Mićović L, Vujović KS, Vucetic C, Kadija M, Mikovic Z. (2011). Pharmacological evaluation of 3-carbomethoxy fentanyl in mice. Pharmaceuticals 4: 233-243.
    Search in Google Scholar
  40. Vučkovic S, Prostran M, Ivanović M, Ristović Z, Stojanović R. (2000). Antinociceptive activity of the novel fentanyl analogue iso-carfentanil in rats. Jpn J Pharmacol 84: 188-195.
    Search in Google Scholar
  41. Vučkovic S, Savić VK, Ivanović M, Došen-Mićović L, Todorovic Z, Vučetić Č., Prostran M., Prostran Milica. (2012). Neurotoxicity evaluation of fentanyl analogs in rats. Acta Veterinaria 62: 3-15.
    Search in Google Scholar
  42. Yassen A, Olofsen E, Kan J, Dahan A, Danhof M. (2008). Pharmacokineticpharmacodynamic modeling of the eff ectiveness and safety of buprenorphine and fentanyl in rats. Pharmaceut Res 25: 183-193.
    Search in Google Scholar
DOI: https://doi.org/10.2478/intox-2014-0013 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Journal RSS Feed
Language: English
Page range: 93 - 102
Submitted on: Apr 8, 2014
Accepted on: Jun 20, 2014
Published on: Nov 15, 2014
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Keywords:
fentanyl analogs,
opioids,
synthesis,
toxicity,
efficacy
Related subjects:
Medicine,
Clinical medicine,
Pharmacology, toxicology

© 2014 Shiv Kumar Yadav, Chandra Kant Maurya, Pradeep Kumar Gupta, Ajai Kumar Jain, Kumaran Ganesan, Rahul Bhattacharya, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 7 (2014): Issue 2 (June 2014)
Previous article
Next article